Patient cracks her own mysterious diagnosis by studying her genetics

Kim Goodsell started noticing physical ailments about 20 years ago, when she was in her 30s and training for an Ironman triathlon. She said she felt “a strange instability” related to the adrenaline of training and had to drop out of the competition.

After finally being diagnosed with 2 rare diseases, “I started looking for what I called the unifying field theory to explain why I had both these conditions,” Goodsell said here at the Future of Genomic Medicine VII.

“As a physician, I’ve never met a patient like her,” Eric Topol, MD, director of the Scripps Translational Science Institute in La Jolla, California, and editor-in-chief of Medscape, said during an interview. “She was able to crack the unifying diagnosis after having been told by the top experts in the country that she simply had bad luck.”

Read the full, original story: Patient Cracks Her Own Mysterious Dual Diagnosis

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-05-12-at-10.05.11-AM
Pro-vaccine “hero” vs. an anti-vax “villain”: ‘Bad Vaxx’ video stirs MAHA backlash
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
ChatGPT Image May 12, 2026, 10_19_00 AM 2
Viewpoint— 'Muscular governance': How authoritarianism is surging corporate-linked energy misinformation
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.